Stephanie Hametner - Publications

The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.

Journal: Journal of gastroenterology

Published: April 10, 2019

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Journal: Wiener klinische Wochenschrift

Published: May 18, 2017

Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.

Journal: The American journal of gastroenterology

Published: May 07, 2016

von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 14, 2015

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.

Journal: PloS one

Published: May 27, 2015

Improving care for victims of violence in resource-poor settings such as Lusaka, Zambia: results of a low-budget intervention.

Journal: Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention

Published: July 29, 2014

Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.

Journal: Alimentary pharmacology & therapeutics

Published: September 14, 2013

Tuberculous sepsis during antiviral HCV triple therapy.

Journal: Journal of hepatology

Published: April 27, 2013